Article
Neuroprotection researchers describe important progress in their field
Since a first symposium on neuroprotection was held at the Associationfor Research in Vision and Ophthalmology (ARVO) meeting 5 years ago, therehave been significant advances in understanding about the mechanisms fordeath of retinal neurons and in the development of neuroprotective therapiesfor glaucoma and other neurodegenerative diseases. At the 2004 annual ARVOmeeting, a panel of leading researchers provided an update on that progressin a symposium entitled "Neuroprotection: Where Are We Now".
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Related Videos
Related Content
